Regeneron Stock Buy Hold or Sell Recommendation

REGN
 Stock
  

USD 613.61  1.35  0.22%   

Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Regeneron Pharmaceuticals is 'Strong Buy'. Macroaxis provides Regeneron Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding REGN positions. The advice algorithm takes into account all of Regeneron Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Regeneron Pharmaceuticals' buy-and-hold perspective. Additionally, take a look at Regeneron Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Regeneron and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Regeneron Pharmaceuticals.

Execute Regeneron Pharmaceuticals Buy or Sell Advice

The Regeneron recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Regeneron Pharmaceuticals. Macroaxis does not own or have any residual interests in Regeneron Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Regeneron Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Regeneron PharmaceuticalsBuy Regeneron Pharmaceuticals
Strong Buy

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very SmallDetails

Economic Sensitivity

Follows the market closelyDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails
For the selected time horizon Regeneron Pharmaceuticals has a Risk Adjusted Performance of (0.06), Jensen Alpha of (0.09), Total Risk Alpha of (0.08) and Treynor Ratio of (0.13)
Macroaxis provides advice on Regeneron Pharmaceuticals to complement and cross-verify current analyst consensus on Regeneron Pharmaceuticals. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Regeneron Pharmaceuticals is not overpriced, please check all Regeneron Pharmaceuticals fundamentals, including its debt to equity, total asset, and the relationship between the ebitda and earnings per share . Given that Regeneron Pharmaceuticals has a number of shares shorted of 2.86 M, we recommend you to check out Regeneron Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Regeneron Pharmaceuticals Trading Alerts and Improvement Suggestions

Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Regeneron Pharmaceuticals has a strong financial position based on the latest SEC filings
Over 88.0% of the company shares are owned by institutional investors
Latest headline from www.defenseworld.net: Phio Pharmaceuticals versus Regeneron Pharmaceuticals Critical Analysis - Defense World

Regeneron Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Regeneron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Regeneron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price683.77
Target Median Price684.00
Target High Price790.00
Recommendation Mean2.40
Number Of Analyst Opinions22
Target Low Price536.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Regeneron Pharmaceuticals Returns Distribution Density

The distribution of Regeneron Pharmaceuticals' historical returns is an attempt to chart the future uncertainty of Regeneron Pharmaceuticals' future price movements. The chart of the probability distribution of Regeneron Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Regeneron Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Regeneron Pharmaceuticals returns is essential to provide solid investment advice for Regeneron Pharmaceuticals stock.
Mean Return-0.09Value At Risk-3.94
Potential Upside3.41Standard Deviation2.09
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Regeneron Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Regeneron Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Regeneron Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regeneron Pharmaceuticals backward and forwards among themselves. Regeneron Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Regeneron Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Sumitomo Mitsui Trust Holdings IncCommon Shares399.3 K236.1 M
Candriam ScaCommon Shares372.8 K220.4 M
New York State Common Retirement FundCommon Shares194.3 K114.9 M
Handelsbanken Fonder AbCommon Shares194.3 K114.9 M
Dekabank Deutsche GirozentraleCommon Shares171.2 K102 M
Mcdonald Capital Investors IncCommon Shares164.1 K97 M
Russell Investments Group LtdCommon Shares160.6 K95.2 M
Note, although Regeneron Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Regeneron Pharmaceuticals Cash Flow Accounts

201720182019202020212022 (projected)
Net Cash Flow from Financing(24.4 M)(77.1 M)(252.1 M)(1.97 B)(1.01 B)(1.03 B)
Net Cash Flow from Investing(1.01 B)(1.46 B)(2.03 B)(70.6 M)(5.38 B)(5.53 B)
Net Cash Flow from Operations1.31 B2.2 B2.43 B2.62 B7.08 B7.64 B

Regeneron Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Regeneron Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Regeneron Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Regeneron stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.09
β
Beta against DOW0.78
σ
Overall volatility
2.00
Ir
Information ratio -0.04

Regeneron Pharmaceuticals Volatility Alert

Regeneron Pharmaceuticals exhibits very low volatility with skewness of 0.0 and kurtosis of 0.76. However, we advise investors to further study Regeneron Pharmaceuticals technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Regeneron Pharmaceuticals' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Regeneron Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Regeneron Pharmaceuticals Implied Volatility

Regeneron Pharmaceuticals' implied volatility" href="/stock-options/REGN/Regeneron-Pharmaceuticals">Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility" href="/stock-options/REGN/Regeneron-Pharmaceuticals">Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options" href="/stock-options/REGN/Regeneron-Pharmaceuticals">Regeneron Pharmaceuticals' options are near their expiration.

Regeneron Pharmaceuticals Fundamentals Vs Peers

Comparing Regeneron Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Regeneron Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Regeneron Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Regeneron Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Regeneron Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Regeneron Pharmaceuticals to competition
FundamentalsRegeneron PharmaceuticalsPeer Average
Return On Equity49.75 %(0.31) %
Return On Asset25.84 %(0.14) %
Profit Margin48.06 %(1.27) %
Operating Margin57.03 %(5.51) %
Current Valuation57.78 B16.62 B
Shares Outstanding108.03 M571.82 M
Shares Owned by Insiders2.69 %10.09 %
Shares Owned by Institutions88.18 %39.21 %
Number of Shares Shorted2.86 M4.71 M
Price to Earning8.23 X28.72 X
Price to Book3.10 X9.51 X
Price to Sales3.83 X11.42 X
Revenue16.51 B9.43 B
Gross Profit10.73 B27.38 B
EBITDA9.41 B3.9 B
Net Income7.93 B570.98 M
Cash and Equivalents7.05 B2.7 B
Cash per Share65.44 X5.01 X
Total Debt2.7 B5.32 B
Debt to Equity0.14 %48.70 %
Current Ratio4.76 X2.16 X
Book Value Per Share185.41 X1.93 K
Cash Flow from Operations8.51 B971.22 M
Short Ratio4.42 X4.00 X
Earnings Per Share69.88 X3.12 X
Price to Earnings To Growth(0.66) X4.89 X
Number of Employees10.49 K18.84 K
Beta0.31-0.15
Market Capitalization63.16 B19.03 B
Total Asset5.61 B29.47 B
Retained Earnings1.7 B9.33 B
Working Capital2.1 B1.48 B
Current Asset2.92 B9.34 B
   Exercise or conversion by Marion McCourt of 1100 shares of Regeneron Pharmaceuticals subject to Rule 16b-3 [view details]

Regeneron Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Regeneron . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution13376.05
Daily Balance Of Power(0.09)
Rate Of Daily Change1.0
Day Median Price614.3
Day Typical Price614.07
Market Facilitation Index0.0
Price Action Indicator(1.36)

About Regeneron Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Regeneron Pharmaceuticals? Buying financial instruments such as Regeneron Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Regeneron Pharmaceuticals investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables2.1 B3.71 B6.04 B6.51 B
Inventories1.42 B1.92 B1.95 B2.11 B

Use Investing Ideas to Build Portfolios

In addition to having Regeneron Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Airlines Thematic Idea Now

Airlines
Airlines Theme
Domestic and international airlines and airline services. The Airlines theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
View All  Next Launch
Additionally, take a look at Regeneron Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.72
Market Capitalization
65.7 B
Quarterly Revenue Growth YOY
-0.44
Return On Assets
0.18
Return On Equity
0.32
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Regeneron Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.